eNauka - pregled

Pregled prema Autor Radulovic, Sinisa S

Prikaz rezultata 1 do 20 od 24  sledeće >
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2021A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory LymphomaCollins, Graham P; ...; Andjelkovic, Nebojsa V; ...; Radulovic, Sinisa S; Tijanic, Ivan  ; ...; (broj, koautora 21)Naučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2019AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan)Todorovic, Vladimir; ...; Babovic, Nada Lj; ...; Četniković, Bojana; Ceric, Timur; ...; Dzamic, Zoran M  ; Dzodic, Radan R ; Eri, Živka ;
...; Knežević-Ušaj, Slavica F ; Kovcin, Vladimir N; ...; Markovic, Ivan Z; Markovic, Milan; Mijalkovic, Nenad; ...; Pantelic, Aleksandra; Popović, Lazar S  ; Radosavljevic, Davorin Z; ...; Radulovic, Sinisa S; ...; Rosic, Ivana; ...; Stamatović, Ljiljana  ; ...; Tesanovic, Dusanka D; Tomasevic, Zorica I  ; Tomasevic, Zoran M; ...; Vasovic, Suzana; Vicko, Ferenc  ; ...; Zarić, Bojan  ; ...; (broj, koautora 65);
Naučni članak
23M23 - Međunarodni časopis kategorije M23
2020Avelumab first-line (1L) maintenance plus best supportive care (BSC) vs BSC alone with 1L chemotherapy (CTx) for advanced urothelial carcinoma (UC): Subgroup analyses from JAVELIN Bladder 100Grivas, P; ...; Radulovic, Sinisa S; ...; (broj, koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma not progressed with first-line chemotherapy: prespecified subgroup analyses from JAVELIN Bladder 100Lumba, Sumit; ...; Radulovic, Sinisa S; ...; (broj, koautora 21)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2004Cardioprotective activities of dexrazoxane (D), amifostine (A) and D,L-alpha-tocopheral (E) against cardiotoxicity of doxorubicin (Dx) alone and in combination with cyclophosphamide (C).Radulovic, Sinisa S; Bjelogrlic, Snezana KKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2007cDNA microarrays: identification of gene signatures and their application in clinical practiceMagic, Zvonko M  ; Radulovic, Sinisa S; Brankovic-Magic, Mirjana V  Naučni članak
Mp kategorija će biti prikazana naknadno.
2007Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriersElsakov, Pavel; Foretova, Lenka; Goetz, Petr; de, Groot Johannes WB; van, der Graaf Winette TA; Guler, Gulnur; Huebner, Kay; Haites, Neva E; Hamann, Ute; Ho, Judy;
Imyanitov, Evgeny N; Irmejs, Arvids; Purkalne, Gunta; Bitina, Marianna; Gardovskis, Andris; Gardovskis, Janis; Kirova, Youlia M; Fourquet, Alain; Pierga, Jean-Yves; Stoppa-Lyonnet, Dominique; Larizza, Lidia; Lips, Cornelis JM; Loman, Niklas; Borg, Ake; Moller, Pal; Olsson, Hakan; Park, Jae-Gahb; Radulovic, Sinisa S; Brankovic-Magic, Mirjana V  ; Rajkumar, Thangarajan; Razis, Evangelia; Yannoukakos, Drakoulis; Schmitt, Fernando; Schmutzler, Rita; Simmonds, Peter D; Eccles, Diana; Smeltzer, Jacob; Silberstein, Peter T; Lynch, Henry; Weber, Walter; Willemse, Pax HB; Sijmons, Rolf H; Wysocki, Piotr J; Zajac, Vladimir; Shu, Zheng;
Naučni članak
Mp kategorija će biti prikazana naknadno.
2000Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: A prospective randomised trialPopov, Ivan P; Jelic, Svetislav B; Radulovic, Sinisa S; Radosavljevic, Davorin Z; Nikolic-Tomasevic, Zorica I  Naučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2003IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTICKonjevic, Gordana M; Jovic, Viktor; Jurisic, Vladimir B  ; Radulovic, Sinisa S; Jelic, Svetislav B; Spuzic, IvanNaučni članak
22M22 - Međunarodni časopis kategorije M22
2004Immunomonitoring and clinical response of patients with metastatic melanoma receiving two chemoimmunotherapy regimensKonjevic, Gordana M; Jovic, Viktor; Radulovic, Sinisa S; Jelic, Svetislav B; Spuzic, IvanKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2001Impaired perforin-dependent NK cell cytotoxicity and proliferative activity of peripheral blood T cells is associated with metastatic melanomaJovic, Viktor; Konjevic, Gordana M; Radulovic, Sinisa S; Jelic, Svetislav B; Spuzic, IvanNaučni članak
23M23 - Međunarodni časopis kategorije M23
2020Maintenance avelumab plus best supportive care (BSC) versus BSC alone after platinum-based first-line (1L) chemotherapy in advanced urothelial carcinoma (UC): JAVELIN Bladder 100 phase III interim analysis.Powles, Thomas; ...; Radulovic, Sinisa S; ...; (broj, koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2008Molecular targeting agents in renal cell carcinoma: Present strategies and future perspectivesBjelogrlic, Snezana K; Radulovic, Sinisa S; Babovic, Nada LjNaučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2003P53 mutations in Yugoslav breast cancer patientsBrankovic-Magic, Mirjana V  ; Jankovic, Radmila N; Magic, Zvonko M  ; Radulovic, Sinisa SKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2000Paclitaxel-cisplatin as first line chemotherapy for undifferentiated carcinoma of the nasopharynx (UCNT): A preliminary report.Jelic, Svetislav B; Babovic, Nada Lj; Stamatovic, Ljiljana; Vucicevic, Slavko S; Pendjer, Ivica P; Radulovic, Sinisa SKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2000Patient statement of satisfaction with antiemetic treatment is related to quality of lifeBosnjak, Snezana M; Radulovic, Sinisa S; Neskovic-Konstantinovic, Zora B; Mitrovic, LBNaučni članak
22M22 - Međunarodni časopis kategorije M22
2013Phase I/LIB Clinical Trial Comparing PK and Safety of Trastuzumab and Its Biosimilar Candidate CT-P6Im, Y; ...; Radulovic, Sinisa S; Nedovic, Jasmina R; (broj, koautora 15)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2022Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancerPowles, Thomas; ...; Radulovic, Sinisa S; ...; (broj, koautora 23)Naučni članak
22M22 - Međunarodni časopis kategorije M22
2009Results of Two Phase I Clinical Trials of MVA-BN (R)-HER2 in HER-2 Overexpressing Metastatic Breast Cancer PatientsGuardino, AE; Cassidy, M; Pienkowski, T; Radulovic, Sinisa S; Legrand, F; Nguyen, A-T; Fernandez, L; Coutts, J; Moore, N; Hwang, O;
Trieger, B; Brand, L; Reiner, L; Delcayre, A; Godfrey, W;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2007Sunitinib, sorafenib and mTOR inhibitors in renal cancerRadulovic, Sinisa S; Bjelogrlic, Snezana KNaučni članak
Mp kategorija će biti prikazana naknadno.